scholarly article | Q13442814 |
P2093 | author name string | H. Suzuki | |
K. Yoshida | |||
M. Tanaka | |||
H. Habuchi | |||
K. Kimata | |||
K. Ban | |||
O. Habuchi | |||
P2860 | cites work | Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities | Q22001454 |
Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci | Q22001455 | ||
Molecular cloning and characterization of human keratan sulfate Gal-6-sulfotransferase | Q24314635 | ||
Molecular characterization and expression of heparan-sulfate 6-sulfotransferase. Complete cDNA cloning in human and partial cloning in Chinese hamster ovary cells | Q24322572 | ||
The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate | Q24323532 | ||
Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? | Q24561731 | ||
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer | Q24564355 | ||
A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
Heparin structure and interactions with basic fibroblast growth factor | Q27732601 | ||
Crystal structure of estrogen sulphotransferase | Q27747076 | ||
Structure of a heparin-linked biologically active dimer of fibroblast growth factor | Q27760195 | ||
Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase | Q28114813 | ||
Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family | Q28118805 | ||
Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans | Q28213234 | ||
Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 | Q28273441 | ||
Regulated diversity of heparan sulfate | Q28282444 | ||
The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate | Q28284035 | ||
Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase | Q28295437 | ||
Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase | Q28589603 | ||
Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity | Q32030968 | ||
Formation of anhydrosugars in the chemical depolymerization of heparin | Q34424006 | ||
Spatially restricted expression of pipe in the Drosophila egg chamber defines embryonic dorsal-ventral polarity | Q34481268 | ||
Molecular Cloning and Expression of Chick Chondrocyte Chondroitin 6-Sulfotransferase | Q36689115 | ||
Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase | Q36861170 | ||
Proteoglycans: structures and interactions | Q37285263 | ||
Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor | Q38288128 | ||
Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor | Q38327052 | ||
An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation | Q38355072 | ||
The coordinated regulation of heparan sulfate, syndecans and cell behavior | Q40780342 | ||
Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions | Q41014679 | ||
Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate | Q41204799 | ||
The role of syndecan-1 in malignancies | Q41227341 | ||
Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease | Q42160698 | ||
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis | Q42476789 | ||
Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells | Q42540063 | ||
Domain structure of heparan sulfates from bovine organs | Q42555942 | ||
Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling | Q47070638 | ||
A sugar fix for bone tumours? | Q47991932 | ||
Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes | Q48037516 | ||
A role of Lys614 in the sulfotransferase activity of human heparan sulfate N-deacetylase/N-sulfotransferase. | Q52184377 | ||
Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. | Q53437765 | ||
T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ | Q59068529 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Heparan sulfate 6-O-sulfotransferase 3 | Q21498556 |
Heparan sulfate 6-O-sulfotransferase 1 | Q21983326 | ||
P304 | page(s) | 2859–2868 | |
P577 | publication date | 2000-01-28 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine | |
P478 | volume | 275 |
Q48773643 | 'Heparin'--from anticoagulant drug into the new biology |
Q33230192 | 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. |
Q38293479 | 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture |
Q46302977 | A highly efficient tree structure for the biosynthesis of heparan sulfate accounts for the commonly observed disaccharides and suggests a mechanism for domain synthesis |
Q24291238 | A novel human Gal-3-O-sulfotransferase: molecular cloning, characterization, and its implications in biosynthesis of (SO(4)-3)Galbeta1-4(Fucalpha1-3)GlcNAc |
Q46594680 | A unique role for 6-O sulfation modification in zebrafish vascular development |
Q38568304 | Analysis of axon guidance defects at the optic chiasm in heparan sulphate sulphotransferase compound mutant mice |
Q35809426 | Anticoagulant heparan sulfate: structural specificity and biosynthesis |
Q35083201 | Applications of isotopes in advancing structural and functional heparanomics |
Q41878618 | Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity |
Q45712959 | Association of HS6ST3 gene polymorphisms with obesity and triglycerides: gene x gender interaction |
Q37415685 | Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site. |
Q34220892 | Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5. |
Q24535653 | Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties |
Q34390846 | Carbohydrate-modifying sulfotransferases: structure, function, and pathophysiology |
Q39295187 | Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes |
Q34464575 | Cell surface heparan sulfate and its roles in assisting viral infections |
Q44436364 | Characterization of a Heparan Sulfate 3-O-Sulfotransferase-5, an Enzyme Synthesizing a Tetrasulfated Disaccharide |
Q28590708 | Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate |
Q79102031 | Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides |
Q48382421 | Combinatorial expression patterns of heparan sulfate sulfotransferases in zebrafish: II. The 6-O-sulfotransferase family |
Q33940136 | Combinatorial roles of heparan sulfate proteoglycans and heparan sulfates in Caenorhabditis elegans neural development. |
Q52364871 | Controlled Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides. |
Q44758118 | Determination of enzyme/substrate specificity constants using a multiple substrate ESI-MS assay |
Q79369812 | Determination of substrate specificity of sulfotransferases and glycosyltransferases (proteoglycans) |
Q45119849 | Differential expression of heparan sulfate 6-O-sulfotransferase isoforms in the mouse embryo suggests distinctive roles during organogenesis |
Q37124609 | Differential roles for 3-OSTs in the regulation of cilia length and motility |
Q36915889 | Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development |
Q48216911 | Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds |
Q33878520 | Diversity and functions of glycosaminoglycan sulfotransferases |
Q48373088 | Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system |
Q35230027 | Enzymatic placement of 6-O-sulfo groups in heparan sulfate |
Q38349606 | Enzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide |
Q52006609 | Enzymatically active N-deacetylase/N-sulfotransferase-2 is present in liver but does not contribute to heparan sulfate N-sulfation. |
Q24555107 | Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo |
Q51986250 | Essential role of heparan sulfate 2-O-sulfotransferase in chick limb bud patterning and development. |
Q39364221 | Genetic Labeling of Nuclei-Specific Thalamocortical Neurons Reveals Putative Sensory-Modality Specific Genes |
Q92541740 | Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications |
Q34947657 | Genetic analysis of the heparan modification network in Caenorhabditis elegans |
Q30353876 | Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes. |
Q47944978 | Genome-wide association studies of albuminuria: towards genetic stratification in diabetes? |
Q35993192 | Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway |
Q35607847 | Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study |
Q64100376 | GlcNAc6ST3 is a keratan sulfate sulfotransferase for the protein-tyrosine phosphatase PTPRZ in the adult brain |
Q35618921 | Glycosylated synaptomatrix regulation of trans-synaptic signaling |
Q38184451 | Growth factor-heparan sulfate "switches" regulating stages of branching morphogenesis |
Q50293277 | HS6STs sulfate GlcN at C6 in heparan sulfate/heparin |
Q35582990 | Heparan Sulfate Core Proteins in Cell-Cell Signaling |
Q99555914 | Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity |
Q35219652 | Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development. |
Q24302044 | Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1 |
Q24307650 | Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism |
Q43215860 | Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin |
Q44463036 | Heparan sulfate 6-o-sulfotransferase is essential for muscle development in zebrafish. |
Q34989559 | Heparan sulfate fine structure and specificity of proteoglycan functions |
Q34989550 | Heparan sulfate proteoglycan modulation of developmental signaling in Drosophila |
Q34029158 | Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. |
Q45023582 | Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups |
Q40724152 | Heparan sulfate-growth factor interactions |
Q31882323 | Heparan sulfate: decoding a dynamic multifunctional cell regulator |
Q46606789 | Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins |
Q26995332 | Human genetic disorders and knockout mice deficient in glycosaminoglycan |
Q39984528 | Hydrogen peroxide as a potential mediator of the transcriptional regulation of heparan sulphate biosynthesis in keratinocytes |
Q46510504 | Identification of L-selectin binding heparan sulfates attached to collagen type XVIII. |
Q37543699 | Interactions between heparan sulfate and proteins-design and functional implications |
Q37784305 | Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1 |
Q28592475 | Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality |
Q24290298 | Molecular cloning and characterization of GalNAc 4-sulfotransferase expressed in human pituitary gland |
Q24290394 | Molecular cloning and characterization of a human beta-Gal-3'-sulfotransferase that acts on both type 1 and type 2 (Gal beta 1-3/1-4GlcNAc-R) oligosaccharides |
Q22253988 | Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase |
Q22253990 | Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family |
Q34310374 | Molecular diversity of heparan sulfate |
Q47143359 | More than a biomarker: the systemic consequences of heparan sulfate fragments released during endothelial surface layer degradation (2017 Grover Conference Series). |
Q89882905 | Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates |
Q92243130 | Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome |
Q31139063 | Oligosaccharide Library-based Assessment of Heparan Sulfate 6-O-Sulfotransferase Substrate Specificity |
Q33675726 | Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling |
Q47104012 | Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer |
Q38318121 | Overexpression of heparan sulfate 6-O-sulfotransferases in human embryonic kidney 293 cells results in increased N-acetylglucosaminyl 6-O-sulfation |
Q38296721 | Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases. |
Q38181492 | Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer |
Q33357090 | Rapid Two-Step Synthesis of Mitrin from Heparosan: A Replacement for Heparin |
Q50693394 | Regulation of heparan sulfate 6-O-sulfation by beta-secretase activity. |
Q34989564 | Role of heparan sulfate-2-O-sulfotransferase in the mouse. |
Q51236565 | Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1. |
Q50644511 | Specific glycosaminoglycans modulate neural specification of mouse embryonic stem cells. |
Q35946290 | Strategies for drug discovery by targeting sulfation pathways |
Q38974435 | Structural alteration of cell surface heparan sulfate through the stimulation of the signaling pathway for heparan sulfate 6-O-sulfotransferase-1 in mouse fibroblast cells. |
Q84978772 | Structural and functional analysis of chondroitin sulfate proteoglycans in the neural stem cell niche |
Q38406589 | Structure Based Substrate Specificity Analysis of Heparan Sulfate 6-O-Sulfotransferases. |
Q34523315 | Structure and biological interactions of heparin and heparan sulfate |
Q22254256 | Structure/function of the human Ga1beta1,3-glucuronosyltransferase. Dimerization and functional activity are mediated by two crucial cysteine residues |
Q38357174 | Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases |
Q39297802 | Sulfated Alginates as Heparin Analogues: A Review of Chemical and Functional Properties. |
Q35910297 | Sulfation pattern in glycosaminoglycan: does it have a code? |
Q34944523 | Sulfotransferases and sulfated oligosaccharides |
Q35532894 | Susceptibility loci revealed for bovine respiratory disease complex in pre-weaned holstein calves |
Q51967151 | Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis. |
Q38290246 | The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. |
Q37228526 | The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation. |
Q36713824 | The biosynthesis and catabolism of galactosaminoglycans |
Q37004231 | The design and synthesis of new synthetic low-molecular-weight heparins |
Q33948367 | The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate |
Q35955763 | The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans. |
Q28513833 | The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse |
Q37596106 | Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis |
Q44235710 | Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling |
Search more.